← Back to Search

Imaging Techniques for Angina

N/A
Waitlist Available
Led By Krishna Patel, MBBS, MSc
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with symptoms of exertional angina and/or dyspnea (confirmed on Seattle Angina Questionnaire and Rose Dyspnea Questionnaire)
Evidence of non-obstructive CAD on CCTA or coronary angiography (no stenosis >50% and/or FFR if performed >0.80)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial looks to develop a non-invasive algorithm to diagnose & manage patients with suspected angina & ischemia but no obstructive coronary artery disease (CAD). It will assess the improvement in patient symptoms, function & quality of life from PET-guided management.

Who is the study for?
This trial is for patients with symptoms of exertional angina or shortness of breath, who have non-obstructive coronary artery disease confirmed by tests. It's not for those with severe kidney issues, certain heart conditions, pregnant women, or people unable to consent.Check my eligibility
What is being tested?
The study aims to develop a non-invasive method using PET scans and other imaging techniques to diagnose and manage microvascular dysfunction in patients without significant coronary artery blockages.See study design
What are the potential side effects?
Potential side effects may include reactions related to the PET imaging agent (like nausea), discomfort from exercise during the stress test, and risks associated with CT angiograms such as radiation exposure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience chest pain or shortness of breath when I exert myself.
Select...
My heart's arteries are not severely blocked.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Euro-QOL 5 Dimension Visual Analog Scale (EQ5D-VAS)
Number of ER admissions for chest pain per participant
Number of use of other invasive or non-invasive diagnostic procedures for CAD
+2 more
Secondary outcome measures
Number of participants with METs >=10 METS
The Bruce protocol score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with INOCAExperimental Treatment4 Interventions
Patients to undergo coronary angiogram and/or coronary CT angiogram for suspected ischemic symptoms of angina and dyspnea but do not have obstructive epicardial coronary artery disease.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PET imaging
2005
Completed Phase 3
~670

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
861 Previous Clinical Trials
525,206 Total Patients Enrolled
Krishna Patel, MBBS, MScPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Media Library

Patients with INOCA Clinical Trial Eligibility Overview. Trial Name: NCT05634031 — N/A
Angina Research Study Groups: Patients with INOCA
Angina Clinical Trial 2023: Patients with INOCA Highlights & Side Effects. Trial Name: NCT05634031 — N/A
Patients with INOCA 2023 Treatment Timeline for Medical Study. Trial Name: NCT05634031 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor have any vacancies for new participants?

"As per the latest update on clinicaltrials.gov, this medical trial is no longer accepting participants; it was first published on December 1st 2022 and has not been updated since November 21st of the same year. Fortunately, there are 574 other studies that remain open for recruitment at present time."

Answered by AI
~33 spots leftby Apr 2025